NOVANT Competition

Bonds . USA . 
Bond . NOVANT 2637 01 NOV 36
66988AAG9   70.65  6.90  8.90%   
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
66.4170.6574.89
Details
Intrinsic
Valuation
LowRealHigh
57.4161.6577.72
Details
Naive
Forecast
LowNextHigh
66.4470.6974.93
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
67.8072.2176.62
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as NOVANT. Your research has to be compared to or analyzed against NOVANT's peers to derive any actionable benefits. When done correctly, NOVANT's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in NOVANT 2637 01.

NOVANT Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between NOVANT and its competitors represents the degree of relationship between the price movements of corresponding bonds. A correlation of about +1.0 implies that the price of NOVANT and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of NOVANT 2637 01 does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SUM
+ 0.76
JBL
MSN
+ 0.66
PMNXF
ALNT
+ 0.54
SUM
MSN
+ 0.49
JBL
JBL
+ 0.44
PMNXF
SUM
+ 0.22
PMNXF
  
High negative correlations   
VINS
- 0.8
SUM
VINS
- 0.79
JBL
ALNT
- 0.51
MSN
VINS
- 0.43
PMNXF
ALNT
- 0.42
PMNXF
MSN
- 0.28
VINS

Risk-Adjusted Indicators

There is a big difference between NOVANT Bond performing well and NOVANT Corporate Bond doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NOVANT's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

NOVANT Competitive Analysis

The better you understand NOVANT competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, NOVANT's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across NOVANT's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
66988AAG9 PMNXF JBL SUM VINS MSN ALNT
 8.90 
 70.65 
NOVANT
 2.27 
 1.72 
Perseus
 0.37 
 131.12 
Jabil
 0.98 
 51.66 
Summit
 0.00 
 0.15 
Vindicator
 6.52 
 0.43 
Emerson
 0.20 
 24.57 
Allient
Market Volatility
(90 Days Market Risk)
Very steady
Dangerous
Very steady
Very steady
Abnormally volatile
Out of control
Very steady
Market Performance
(90 Days Performance)
Very Weak
Weak
Good
Good
Very Weak
Very Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
About Average
Low
Very Low
Very Low
Low
Low
Very Small
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Strong Buy
Not Available
Not Available
Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Hold
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
3.68 X
1.01 X
3.17 X
N/A
20.59 X
N/A
Net Asset
N/A
1.99 B
17.35 B
5.15 B
N/A
29.07 M
597.54 M
Profit Margin
N/A
0.21 %
0.05 %
0.04 %
N/A
0.04 %
0.03 %
EBITDA
N/A
504.39 M
2.13 B
546.7 M
N/A
887 K
83.35 M
Operating Margin
N/A
0.24 %
0.05 %
0.17 %
N/A
(0.56) %
0.06 %
Current Valuation
N/A
1.85 B
15.85 B
11.22 B
N/A
(3.79 M)
632.94 M
Price To Book
N/A
2.04 X
8.52 X
2.04 X
N/A
0.43 X
1.52 X
Retained Earnings
N/A
37 M
5.76 B
876.75 M
N/A
(24.2 M)
165.81 M
Current Asset
N/A
270 M
5.85 B
472.53 M
N/A
58.33 M
N/A
Five Year Return
N/A
N/A
0.88 %
N/A
N/A
N/A
N/A
Beta
N/A
0.89
1.25
1.14
-0.05
0.47
1.51
Number Of Employees
N/A
25
138 K
5.3 K
10
25
2.29 K
Shares Outstanding
N/A
1.37 B
112.84 M
175.6 M
N/A
21.04 M
16.85 M
Cash Flow From Operations
N/A
522.91 M
1.72 B
438.86 M
N/A
(5.26 M)
45.04 M
Annual Yield
N/A
0.02 %
0 %
N/A
N/A
N/A
0 %
Total Debt
N/A
72.54 M
3.26 B
2.33 B
N/A
291 K
243.49 M
Return On Equity
N/A
0.21
0.6
0.0436
N/A
0.0147
0.0563
Z Score
N/A
14.4
N/A
N/A
N/A
N/A
N/A
Return On Asset
N/A
0.1
0.0492
0.0464
N/A
-0.0797
0.0345
Book Value Per Share
N/A
1.08 X
15.27 X
25.32 X
N/A
1.09 X
16.20 X
Number Of Shares Shorted
N/A
N/A
3.09 M
3.72 M
N/A
150.44 K
256.68 K
Current Liabilities
N/A
111 M
5.57 B
214.5 M
N/A
2.66 M
N/A
Total Asset
N/A
1.99 B
17.35 B
5.15 B
N/A
29.07 M
597.54 M
Debt To Equity
N/A
0.05 %
1.52 %
0.81 %
N/A
0.01 %
N/A
Last Dividend Paid
N/A
0.025
0.32
N/A
N/A
N/A
0.12
Short Ratio
N/A
N/A
2.51 X
2.22 X
N/A
23.47 X
2.11 X
Target Price
N/A
N/A
144.88
52.55
N/A
N/A
29.33
Shares Owned By Institutions
N/A
59.31 %
95.20 %
71.06 %
N/A
4.40 %
67.70 %
Market Capitalization
N/A
1.81 B
14.8 B
9.07 B
N/A
9.11 M
413.89 M
Price To Earning
N/A
23.28 X
10.24 X
25.03 X
N/A
(37.00) X
N/A
Price To Earnings To Growth
N/A
N/A
0.91 X
1.44 X
N/A
N/A
N/A
Price To Sales
N/A
1.74 X
0.51 X
2.42 X
N/A
0.96 X
0.75 X
Net Income
N/A
233.59 M
1.39 B
285.86 M
N/A
766 K
24.1 M
Earnings Per Share
N/A
0.12 X
11.17 X
0.85 X
N/A
(0.15) X
0.87 X
Shares Owned By Insiders
N/A
0.69 %
3.12 %
31.91 %
N/A
72.40 %
15.70 %
Revenue
N/A
1.13 B
28.88 B
2.62 B
N/A
9.07 M
578.63 M
Working Capital
N/A
159 M
1.01 B
1.41 B
N/A
26.63 M
152.53 M
Cash And Equivalents
N/A
426.85 M
1.8 B
520.45 M
N/A
25.27 M
N/A
Cash Per Share
N/A
0.31 X
11.10 X
3.93 X
N/A
1.18 X
N/A
Gross Profit
N/A
564.14 M
2.87 B
649.35 M
N/A
2.1 M
157.26 M
Day Typical Price
70.65
1.72
130.7
51.42
0.15
0.44
24.64
Accumulation Distribution
N/A
N/A
0.0154
0.0176
N/A
0.0851
0.0264
Market Facilitation Index
N/A
N/A
2.03
0.91
N/A
0.04
0.66
Daily Balance Of Power
(9,223,372,036,855)
(9,223,372,036,855)
0.2365
0.5495
0.0
(0.75)
(0.08)
Period Momentum Indicator
(6.90)
(0.04)
0.48
0.5
N/A
(0.03)
(0.05)
Rate Of Daily Change
0.91
0.98
1.0
1.01
1.0
0.93
1.0
Day Median Price
70.65
1.72
130.5
51.31
0.15
0.45
24.68
Price Action Indicator
(3.45)
(0.02)
0.87
0.6
N/A
(0.04)
(0.14)
Relative Strength Index
79.29
69.76
55.43
88.8
N/A
49.18
59.18
Coefficient Of Variation
(4,273)
8332.49
661.87
525.18
(812.40)
(56,465)
924.01
Mean Deviation
1.28
2.47
1.33
1.71
0.1865
2.34
2.14
Jensen Alpha
(0.03)
(0.06)
0.118
0.2346
(0.09)
(0.05)
0.0672
Total Risk Alpha
(0.47)
(0.51)
(0.02)
0.0669
(0.23)
(0.58)
(0.15)
Sortino Ratio
N/A
(0.02)
0.1322
0.1443
N/A
N/A
0.0673
Downside Variance
N/A
16.38
2.28
4.74
N/A
N/A
6.51
Standard Deviation
2.52
3.46
2.19
2.34
0.7693
3.57
2.8
Kurtosis
16.18
1.37
11.75
1.89
66.0
1.13
0.9029
Potential Upside
2.14
6.32
2.8
4.18
N/A
6.82
5.25
Treynor Ratio
0.2082
0.0406
0.1912
0.2623
0.7676
(0.05)
0.1568
Maximum Drawdown
16.11
20.57
15.06
9.88
6.25
16.89
11.31
Variance
6.36
11.96
4.78
5.46
0.5919
12.73
7.82
Market Risk Adjusted Performance
0.2182
0.0506
0.2012
0.2723
0.7776
(0.04)
0.1668
Risk Adjusted Performance
(0.01)
0.017
0.1224
0.1528
(0.09)
0.0065
0.0903
Skewness
0.4084
(0.01)
2.34
0.3179
(8.12)
0.1909
0.3766
Semi Deviation
N/A
3.45
1.21
1.74
N/A
N/A
2.41
Information Ratio
(0.08)
(0.03)
0.0913
0.1344
(0.29)
(0.04)
0.0615
Value At Risk
(2.38)
(5.71)
(2.04)
(2.73)
N/A
(5.88)
(4.45)
Expected Short fall
N/A
(2.59)
(1.58)
(1.92)
N/A
N/A
(2.38)
Downside Deviation
N/A
4.05
1.51
2.18
N/A
N/A
2.55
Semi Variance
N/A
11.87
1.47
3.04
N/A
N/A
5.79

NOVANT Competition Performance Charts

Five steps to successful analysis of NOVANT Competition

NOVANT's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by NOVANT 2637 01 in relation to its competition. NOVANT's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of NOVANT in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact NOVANT's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to NOVANT 2637 01, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your NOVANT position

In addition to having NOVANT in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare
Healthcare Theme
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in NOVANT Bond

NOVANT financial ratios help investors to determine whether NOVANT Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVANT with respect to the benefits of owning NOVANT security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY